+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Allergic Rhinitis Drugs Market Research Report by Route of Administration, Class of Drugs, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 221 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 4905052
UP TO OFF until Dec 31st 2022
The Global Allergic Rhinitis Drugs Market size was estimated at USD 4,347.46 million in 2021, USD 4,543.02 million in 2022, and is projected to grow at a CAGR of 4.67% to reach USD 5,718.77 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Allergic Rhinitis Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Route of Administration, the market was studied across Intranasal, Intraocular, Oral, and Parenteral.
  • Based on Class of Drugs, the market was studied across Antihistamines, Immunotherapies, and Intranasal Corticosteroids.
  • Based on Application, the market was studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Allergic Rhinitis Drugs market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Allergic Rhinitis Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Allergic Rhinitis Drugs Market, including A-S Medication Solutions, Adamis Pharmaceuticals, Alcon, Amneal Pharmaceuticals LLC, Apotex Corp, Ascend Laboratories, LLC, AvKARE, Belcher Pharmaceuticals, Bristol Myers Squibb Pharma, Dr. Reddy’s Laboratories, Inc., Fosun Pharma USA Inc, Gland Pharma Limited, GlaxoSmithKline, Janssen Biotech, Inc., MEDA Pharmaceuticals, Merck, Mitsubishi Tanabe Pharma, Mylan Pharmaceuticals Inc., Novartis, Perrigo New York Inc., Pfizer, Physicians Total Care, Inc., Sandoz Inc, Sanofi, Shoreline Pharmaceuticals, Inc., and Sun Pharmaceutical Industries, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Allergic Rhinitis Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Allergic Rhinitis Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Allergic Rhinitis Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Allergic Rhinitis Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Allergic Rhinitis Drugs Market?
6. What is the market share of the leading vendors in the Global Allergic Rhinitis Drugs Market?
7. What modes and strategic moves are considered suitable for entering the Global Allergic Rhinitis Drugs Market?
Frequently Asked Questions about the Global Allergic Rhinitis Drugs Market

What is the estimated value of the Global Allergic Rhinitis Drugs Market?

The Global Allergic Rhinitis Drugs Market was estimated to be valued at $4347.46 Million in 2021.

What is the growth rate of the Global Allergic Rhinitis Drugs Market?

The growth rate of the Global Allergic Rhinitis Drugs Market is 4.6%, with an estimated value of $5718.77 Million by 2027.

What is the forecasted size of the Global Allergic Rhinitis Drugs Market?

The Global Allergic Rhinitis Drugs Market is estimated to be worth $5718.77 Million by 2027.

Who are the key companies in the Global Allergic Rhinitis Drugs Market?

Key companies in the Global Allergic Rhinitis Drugs Market include A, S Medication Solutions, Adamis Pharmaceuticals, Alcon, Amneal Pharmaceuticals LLC, Apotex Corp, Ascend Laboratories, LLC, AvKARE and Bristol Myers Squibb Pharma.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of allergic rhinitis
5.1.1.2. Increasing lifestyle changes attributes to growing use of tobacco promotes allergic rhinitis
5.1.1.3. Availability of different modes of administration such as nasal sprays increases demand for allergic rhinitis drugs
5.1.1.4. Demand for over-the-counter drugs
5.1.2. Restraints
5.1.2.1. Reduced specificity of symptoms for allergic rhinitis
5.1.3. Opportunities
5.1.3.1. Growing development and commercialization of allergic rhinitis drugs
5.1.3.2. Increasing government and organization initiatives to increase the awareness of allergic rhinitis
5.1.4. Challenges
5.1.4.1. No standard cure for allergic rhinitis
5.2. Cumulative Impact of COVID-19
6. Allergic Rhinitis Drugs Market, by Route of Administration
6.1. Introduction
6.2. Intranasal
6.3. Intraocular
6.4. Oral
6.5. Parenteral
7. Allergic Rhinitis Drugs Market, by Class of Drugs
7.1. Introduction
7.2. Antihistamines
7.3. Immunotherapies
7.4. Intranasal Corticosteroids
8. Allergic Rhinitis Drugs Market, by Application
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Online Pharmacy
8.4. Retail Pharmacy
9. Americas Allergic Rhinitis Drugs Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Allergic Rhinitis Drugs Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Allergic Rhinitis Drugs Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. A-S Medication Solutions
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Adamis Pharmaceuticals
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Alcon
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Amneal Pharmaceuticals LLC
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Apotex Corp
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Ascend Laboratories, LLC
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. AvKARE
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Belcher Pharmaceuticals
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Bristol Myers Squibb Pharma
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Dr. Reddy’s Laboratories, Inc.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Fosun Pharma USA Inc
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Gland Pharma Limited
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. GlaxoSmithKline
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Janssen Biotech, Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. MEDA Pharmaceuticals
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Merck
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Mitsubishi Tanabe Pharma
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Mylan Pharmaceuticals Inc.
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Novartis
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Perrigo New York Inc.
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Pfizer
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Physicians Total Care, Inc.
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Sandoz Inc
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Sanofi
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
13.25. Shoreline Pharmaceuticals, Inc.
13.25.1. Business Overview
13.25.2. Key Executives
13.25.3. Product & Services
13.26. Sun Pharmaceutical Industries, Inc.
13.26.1. Business Overview
13.26.2. Key Executives
13.26.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ALLERGIC RHINITIS DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL ALLERGIC RHINITIS DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL ALLERGIC RHINITIS DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL ALLERGIC RHINITIS DRUGS MARKET DYNAMICS
FIGURE 11. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (%)
FIGURE 12. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL ALLERGIC RHINITIS DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY ROUTE OF ADMINISTRATION, 2027
FIGURE 14. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRANASAL, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRAOCULAR, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ORAL, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY PARENTERAL, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2021 VS 2027 (%)
FIGURE 19. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL ALLERGIC RHINITIS DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY CLASS OF DRUGS, 2027
FIGURE 21. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ANTIHISTAMINES, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRANASAL CORTICOSTEROIDS, 2018-2027 (USD MILLION)
FIGURE 24. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 25. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL ALLERGIC RHINITIS DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2027
FIGURE 27. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2027 (USD MILLION)
FIGURE 28. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2027 (USD MILLION)
FIGURE 30. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 31. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 32. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 33. AMERICAS ALLERGIC RHINITIS DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 34. ARGENTINA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. BRAZIL ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. CANADA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. MEXICO ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 40. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 41. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 42. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 44. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 45. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 46. AUSTRALIA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. CHINA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. INDIA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. INDONESIA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. JAPAN ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. MALAYSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. PHILIPPINES ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. SINGAPORE ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. SOUTH KOREA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. TAIWAN ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. THAILAND ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. VIETNAM ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 62. DENMARK ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. EGYPT ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. FINLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. FRANCE ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. GERMANY ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. ISRAEL ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. ITALY ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. NETHERLANDS ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. NIGERIA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. NORWAY ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. POLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. QATAR ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. RUSSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. SAUDI ARABIA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. SOUTH AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. SPAIN ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. SWEDEN ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. SWITZERLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. TURKEY ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. UNITED ARAB EMIRATES ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. UNITED KINGDOM ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. GLOBAL ALLERGIC RHINITIS DRUGS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 84. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 85. GLOBAL ALLERGIC RHINITIS DRUGS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRANASAL, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRAOCULAR, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRAOCULAR, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRAOCULAR, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ORAL, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY PARENTERAL, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ANTIHISTAMINES, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY IMMUNOTHERAPIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY IMMUNOTHERAPIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRANASAL CORTICOSTEROIDS, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRANASAL CORTICOSTEROIDS, BY REGION, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRANASAL CORTICOSTEROIDS, BY REGION, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 33. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 35. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 36. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2027 (USD MILLION)
TABLE 37. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 38. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 39. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 41. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 42. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 43. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 44. ARGENTINA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 45. ARGENTINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 46. ARGENTINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 47. ARGENTINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 48. BRAZIL ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 49. BRAZIL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 50. BRAZIL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 51. BRAZIL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 52. CANADA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 53. CANADA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 54. CANADA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 55. CANADA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 56. MEXICO ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 57. MEXICO ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 58. MEXICO ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 59. MEXICO ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 60. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 61. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 62. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 63. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 64. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 65. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 66. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 67. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 68. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 69. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 70. AUSTRALIA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 71. AUSTRALIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 72. AUSTRALIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 73. AUSTRALIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 74. CHINA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 75. CHINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 76. CHINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 77. CHINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 78. INDIA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 79. INDIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 80. INDIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 81. INDIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 82. INDONESIA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 83. INDONESIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 84. INDONESIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 85. INDONESIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 86. JAPAN ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 87. JAPAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 88. JAPAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 89. JAPAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 90. MALAYSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 91. MALAYSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 92. MALAYSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 93. MALAYSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 94. PHILIPPINES ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 95. PHILIPPINES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 96. PHILIPPINES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 97. PHILIPPINES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 98. SINGAPORE ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 99. SINGAPORE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 100. SINGAPORE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 101. SINGAPORE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 102. SOUTH KOREA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 103. SOUTH KOREA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 104. SOUTH KOREA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 105. SOUTH KOREA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 106. TAIWAN ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 107. TAIWAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 108. TAIWAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 109. TAIWAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 110. THAILAND ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 111. THAILAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 112. THAILAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 113. THAILAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 114. VIETNAM ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 115. VIETNAM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 116. VIETNAM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 117. VIETNAM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 123. DENMARK ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 124. DENMARK ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 125. DENMARK ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 126. DENMARK ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 127. EGYPT ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 128. EGYPT ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 129. EGYPT ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 130. EGYPT ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 131. FINLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 132. FINLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 133. FINLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 134. FINLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 135. FRANCE ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 136. FRANCE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 137. FRANCE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 138. FRANCE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 139. GERMANY ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 140. GERMANY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 141. GERMANY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 142. GERMANY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 143. ISRAEL ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 144. ISRAEL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 145. ISRAEL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 146. ISRAEL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 147. ITALY ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 148. ITALY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 149. ITALY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 150. ITALY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 151. NETHERLANDS ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 152. NETHERLANDS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 153. NETHERLANDS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 154. NETHERLANDS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 155. NIGERIA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 156. NIGERIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 157. NIGERIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 158. NIGERIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 159. NORWAY ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 160. NORWAY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 161. NORWAY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 162. NORWAY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 163. POLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 164. POLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 165. POLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 166. POLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 167. QATAR ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 168. QATAR ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 169. QATAR ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 170. QATAR ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 171. RUSSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 172. RUSSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 173. RUSSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 174. RUSSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 175. SAUDI ARABIA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 176. SAUDI ARABIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 177. SAUDI ARABIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 178. SAUDI ARABIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 179. SOUTH AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 180. SOUTH AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 181. SOUTH AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 182. SOUTH AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 183. SPAIN ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 184. SPAIN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 185. SPAIN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 186. SPAIN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 187. SWEDEN ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 188. SWEDEN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 189. SWEDEN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 190. SWEDEN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 191. SWITZERLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 192. SWITZERLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 193. SWITZERLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 194. SWITZERLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 195. TURKEY ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 196. TURKEY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 197. TURKEY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 198. TURKEY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 203. UNITED KINGDOM ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 204. UNITED KINGDOM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 205. UNITED KINGDOM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 206. UNITED KINGDOM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 207. GLOBAL ALLERGIC RHINITIS DRUGS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 208. GLOBAL ALLERGIC RHINITIS DRUGS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 209. GLOBAL ALLERGIC RHINITIS DRUGS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 210. GLOBAL ALLERGIC RHINITIS DRUGS MARKET RANKING, BY KEY PLAYER, 2021
TABLE 211. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 212. GLOBAL ALLERGIC RHINITIS DRUGS MARKET MERGER & ACQUISITION
TABLE 213. GLOBAL ALLERGIC RHINITIS DRUGS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 214. GLOBAL ALLERGIC RHINITIS DRUGS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 215. GLOBAL ALLERGIC RHINITIS DRUGS MARKET INVESTMENT & FUNDING
TABLE 216. GLOBAL ALLERGIC RHINITIS DRUGS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 217. GLOBAL ALLERGIC RHINITIS DRUGS MARKET: LICENSE & PRICING

Companies Mentioned

  • A-S Medication Solutions
  • Adamis Pharmaceuticals
  • Alcon
  • Amneal Pharmaceuticals LLC
  • Apotex Corp
  • Ascend Laboratories, LLC
  • AvKARE
  • Belcher Pharmaceuticals
  • Bristol Myers Squibb Pharma
  • Dr. Reddy's Laboratories, Inc.
  • Fosun Pharma USA Inc
  • Gland Pharma Limited
  • GlaxoSmithKline
  • Janssen Biotech, Inc.
  • MEDA Pharmaceuticals
  • Merck
  • Mitsubishi Tanabe Pharma
  • Mylan Pharmaceuticals Inc.
  • Novartis
  • Perrigo New York Inc.
  • Pfizer
  • Physicians Total Care, Inc.
  • Sandoz Inc
  • Sanofi
  • Shoreline Pharmaceuticals, Inc.
  • Sun Pharmaceutical Industries, Inc.

Methodology

Loading
LOADING...